These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36582903)

  • 21. Outcomes in patients with cardiac amyloidosis and implantable cardioverter-defibrillator.
    Kim EJ; Holmes BB; Huang S; Lugo R; Al Aboud A; Goodman S; Hung RR; Slosky D; Stevenson WG; Michaud GF; John RM
    Europace; 2020 Aug; 22(8):1216-1223. PubMed ID: 32514579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term clinical outcome in patients with severe left ventricular dysfunction and an implantable cardioverter-defibrillator after ventricular tachyarrhythmias.
    Pelicano N; Oliveira M; Da Silva N; Antunes E; Santos S; Conceição JM; Roquette J; Quininha J
    Rev Port Cardiol; 2005 Apr; 24(4):487-98. PubMed ID: 15977773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac Implantable Electronic Devices: A Window Into the Evolution of Conduction Disease in Cardiac Amyloidosis.
    Rehorn MR; Loungani RS; Black-Maier E; Coniglio AC; Karra R; Pokorney SD; Khouri MG
    JACC Clin Electrophysiol; 2020 Sep; 6(9):1144-1154. PubMed ID: 32972550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequencies and types of arrhythmias in patients with systemic light-chain amyloidosis with cardiac involvement undergoing stem cell transplantation on telemetry monitoring.
    Goldsmith YB; Liu J; Chou J; Hoffman J; Comenzo RL; Steingart RM
    Am J Cardiol; 2009 Oct; 104(7):990-4. PubMed ID: 19766769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis.
    Sayed RH; Rogers D; Khan F; Wechalekar AD; Lachmann HJ; Fontana M; Mahmood S; Sachchithanantham S; Patel K; Hawkins PN; Whelan CJ; Gillmore JD
    Eur Heart J; 2015 May; 36(18):1098-105. PubMed ID: 25549725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Electrocardiographic Follow-Up of a Patient with Light-Chain Cardiac Amyloidosis.
    Ohara T; Murata H; Yodogawa K; Yasutake M
    J Nippon Med Sch; 2022 Mar; 89(1):119-125. PubMed ID: 33692307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interventional electrophysiology and its role in the treatment of cardiac arrhythmia.
    Teo WS; Kam R; Tan A
    Ann Acad Med Singap; 1998 Mar; 27(2):248-54. PubMed ID: 9663319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of cardiovascular magnetic resonance characteristics and clinical prognosis in left ventricular noncompaction patients with and without arrhythmia.
    Zhou ZQ; He WC; Li X; Bai W; Huang W; Hou RL; Wang YN; Guo YK
    BMC Cardiovasc Disord; 2022 Feb; 22(1):25. PubMed ID: 35109817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
    Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
    J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
    Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case report: Short-long-short mechanism triggering sustained ventricular tachycardia in a patient with a single-chamber ICD but inhibiting antitachycardia therapy.
    Schernthaner C; Topf A; Motloch LJ; Kraus J; Hauptmann L; Hoppe UC; Strohmer B
    Front Cardiovasc Med; 2022; 9():984262. PubMed ID: 36093158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mode of death and outcomes of implantable cardioverter defibrillators in transthyretin amyloid cardiomyopathy.
    Dale Z; Al-Rashdan L; Elman M; Chandrashekar P; Heitner SB; Nazer B; Masri A
    Int J Cardiol; 2022 Feb; 349():99-102. PubMed ID: 34843821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Camm CF; James CA; Tichnell C; Murray B; Bhonsale A; te Riele AS; Judge DP; Tandri H; Calkins H
    Heart Rhythm; 2013 Nov; 10(11):1661-8. PubMed ID: 23994726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac amyloidosis presenting with prolonged QT interval and recurrent polymorphic ventricular tachycardia.
    Gilotra NA; Chow GV; Cingolani OH
    Tex Heart Inst J; 2013; 40(2):193-5. PubMed ID: 23678221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ICD implantation on cardiovascular outcomes in patients with cardiac amyloidosis: A systematic review and meta-anaylsis.
    Halawa A; Woldu HG; Kacey KG; Alpert MA
    J Cardiovasc Electrophysiol; 2020 Jul; 31(7):1749-1758. PubMed ID: 32391952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of Arrhythmias in Cardiac Amyloidosis.
    Giancaterino S; Urey MA; Darden D; Hsu JC
    JACC Clin Electrophysiol; 2020 Apr; 6(4):351-361. PubMed ID: 32327068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Arrhythmia, device interventions and mortality analysis in patients with implanted cardioverter-defibrillator with/without resynchronisation therapy in dilative cardiomyopathy in primary prevention of sudden cardiac death].
    Lelakowski J; Pudło J; Lelakowska-Pieła M; Rydlewska A; Piekarz J; Domaracki D
    Pol Merkur Lekarski; 2016 Apr; 40(238):216-22. PubMed ID: 27137820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): A Multicenter Randomized Trial.
    Willems S; Tilz RR; Steven D; Kääb S; Wegscheider K; Gellér L; Meyer C; Heeger CH; Metzner A; Sinner MF; Schlüter M; Nordbeck P; Eckardt L; Bogossian H; Sultan A; Wenzel B; Kuck KH;
    Circulation; 2020 Mar; 141(13):1057-1067. PubMed ID: 32000514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.